Dana M. Litturi, D.m.d., Llc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 6 Parc Pl, Suite C, Southampton, MA 01073 Phone: 413-203-1919 Fax: 413-203-5090 |
Fallon Dental Arts, Pllc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 6 Parc Pl Ste C, Southampton, MA 01073 Phone: 413-203-1919 Fax: 413-203-5090 |
Southampton Family Dentistry, Pc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 4 Line St, Southampton, MA 01073 Phone: 413-527-5205 |
Southampton Family Dentistry, Llc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 4 Line Street, Southampton, MA 01073 Phone: 413-527-5205 Fax: 413-527-7822 |
News Archive
The National Organization for Rare Disorders has awarded a research grant for the study of stiff-person syndrome, a rare acquired neurological disorder, to Eric Lancaster, MD, PhD of the University of Pennsylvania.
A research team led by scientists at the Columbia University Mailman School of Public Health report on a new method to help health officials control outbreaks of methicillin-resistant Staphylococcus aureus, or MRSA, a life-threatening antibiotic-resistant infection often seen in hospitals.
The subject of extensive studies across the world, Resveratrol is proving to be a major talking point in the scientific community. And as evidence comes to light of the continuing beneficial effects of this compound, a further study by the University of Northumbria in the UK has confirmed what many scientists already believe to be the case - that Resveratrol could have a significant impact on the cognitive processes of the human brain.
Revolutions Medical Corporation announces a major breakthrough in automatic retractable prefilled safety syringe technology. Building on the Company's proprietary vacuum based technology, important improvements in performance have been made that will set a new gold standard for safety in automatic prefilled syringes.
A new technology assessment from the American Society of Clinical Oncology states that the use of chemotherapy sensitivity and resistance assays (CSRAs) to select chemotherapeutic agents for cancer patients should not be undertaken outside of the clinical trial setting.
› Verified 2 days ago